1. Home
  2. Companies
  3. Windtree Therapeutics
  4. Financial Ratios
  5. ROCE Ratio
Windtree Therapeutics logo
Windtree Therapeutics WINT

Quarterly report 2025-Q3
added 05-23-2026

report update icon

Windtree Therapeutics ROCE Ratio 2011-2026 | WINT

Annual ROCE Ratio Windtree Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
-261.49 -607.4 -412.83 -184.52 -28.4 -24.01 -19.78 198.79 1030.23 -154.89 -109.04 -57.51 -207.8 -1114.09 -423.63 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1030.23 -1114.09 -158.43

Quarterly ROCE Ratio Windtree Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-86.51 -585.52 -503.6 -463.86 -526.52 -477.22 -209.09 -180.52 -207.21 -235.91 -201.67 -142.05 -158.28 -211.5 -130.07 -106.07 -118.59 -113.78 -43.5 -33.58 -39.66 -36.73 -33.97 -33.22 -34.26 -29.76 -25.55 -23.78 -2.03 23.1 53.23 94.26 101.73 108.51 117.5 131.93 -8.48 -137.45 -298.37 -481.9 -422.05 -373.69 -304.42 -225.31 -184.39 -149.08 -110.57 -76.08 -128.92 -167.07 -198.53 -214.24 -610.86 -1042.36 -1497.16 -1939.24 -488.13 -504.75 -479.35

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
131.93 -1939.24 -244.17

ROCE Ratio of other stocks in the Biotechnology industry

Issuer ROCE Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		-299.89 - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		2.89 - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		-27.78 - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
 		64924.32 - -10.17 % $ 12.2 K usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		-60.12 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		17.36 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		-49.48 - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
 		3539.01 - -13.47 % $ 169 M franceFrance
AstraZeneca PLC AstraZeneca PLC
AZN
 		16.47 - - $ 96.9 B britainBritain
BioNTech SE BioNTech SE
BNTX
 		-7.08 $ 89.59 - $ 21.7 B germanyGermany
Compugen Ltd. Compugen Ltd.
CGEN
 		23.38 $ 2.22 - $ 207 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		-61.36 - -1.52 % $ 24.7 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
 		-296.87 $ 1.58 - $ 185 M usaUSA
Athira Pharma Athira Pharma
ATHA
 		-368.0 - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
 		-41.41 - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
 		-1.18 - - $ 4.9 B britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
 		-63.97 - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		-71.74 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		-149.7 - -34.95 % $ 21.5 M germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		15.18 - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		-88.5 - - $ 231 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		-439.8 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		-69.03 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		-54.51 $ 29.93 - $ 1.99 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		-165.18 - - $ 344 M usaUSA
IMV IMV
IMV
 		-79.29 - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		-38.05 - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
 		-37.16 - 0.23 % $ 488 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
 		-0.65 $ 0.79 - $ 36.1 M israelIsrael
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		3412.47 - - $ 7.46 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
 		-19.96 $ 3.13 - $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
 		-3.23 $ 28.9 - $ 778 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		-123.17 - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		-187.83 - - $ 384 M britainBritain
Forte Biosciences Forte Biosciences
FBRX
 		-115.85 $ 16.69 - $ 216 M usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
 		-45.4 - - $ 3.37 B chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
 		-7.7 $ 14.79 - $ 212 M usaUSA
Advaxis Advaxis
ADXS
 		429.74 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		-76.42 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		-29.3 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		-51.5 - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		-60.13 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		-80.33 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		-146.69 $ 3.16 - $ 5.2 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
 		-46.69 - -45.71 % $ 1.2 M canadaCanada
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		-34.58 $ 56.95 - $ 5.12 B schweizSchweiz
Aptinyx Aptinyx
APTX
 		-163.42 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		-70.32 - -0.23 % $ 916 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
 		15.7 $ 2.38 - $ 152 M usaUSA